Level of sedation in the ICU.
Conditions
Interventions
Intervention 1: Intervention group 1: In this group, patients are assessed for disease severity and hemodynamic status upon admission to the ICU, and their vital signs are recorded. Then, they receive
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients admitted to the ICU with a physical status of ASA II or ASA III Age between 18 and 60 years Need for light sedation at the discretion of the attending physician Written consent from the patient or legal guardian in case of anesthesia or decision-making incapacity
Exclusion criteria
Exclusion criteria: Known hypersensitivity to midazolam or other benzodiazepines or methadone Severe hepatic or renal impairment Concomitant use of other potent sedatives Pregnancy or lactation Severe hemodynamic or respiratory disorders that, in the opinion of the attending physician, preclude entry into the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation level. Timepoint: At 15, 30, 60 and 120 minutes after injection. Method of measurement: Ramsay scale.;Side effects include hypotension, difficulty breathing, and local reactions at the injection site. Timepoint: At 15, 30, 60 and 120 minutes after injection. Method of measurement: By observing and assessing hemodynamic status.;Satisfaction of medical staff. Timepoint: After the end of the interventions in each patient. Method of measurement: Standard questionnaire with Likert scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehzad Nazem Roaya Sade
Esfahan University of Medical Sciences
Outcome results
None listed